Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Biobizkaia (10)

2024

  1. Incorporating PHI in decision making: external validation of the Rotterdam risk calculators for detection of prostate cancer

    World journal of urology, Vol. 42, Núm. 1, pp. 141

2023

  1. Do PHI and PHI density improve detection of clinically significant prostate cancer only in the PSA gray zone?

    Clinica Chimica Acta, Vol. 542

2022

  1. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study)

    Journal of Thrombosis and Thrombolysis, Vol. 53, Núm. 1, pp. 103-112

  2. Misidentification of the SARS-CoV-2 Mu variant using commercial mutation screening assays

    Archives of Virology, Vol. 167, Núm. 4, pp. 1141-1144

  3. The Prevention of Ischemia-Reperfusion Injury in Elderly Rats after Lower Limb Tourniquet Use

    Antioxidants, Vol. 11, Núm. 10

2021

  1. Cardiac troponin and COVID-19 severity: Results from BIOCOVID study

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  2. Characteristics and laboratory findings on admission to the emergency department among 2873 hospitalized patients with COVID-19: the impact of adjusted laboratory tests in multicenter studies. A multicenter study in Spain (BIOCOVID-Spain study)

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 81, Núm. 3, pp. 187-193

  3. Curcumin reduces colorectal cancer cell proliferation and migration and slows in vivo growth of liver metastases in rats

    Biomedicines, Vol. 9, Núm. 9

  4. Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection

    Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 81, Núm. 5, pp. 394-400

2020

  1. Ultrasound Tumor Size Assessment, Histology and Serum Enzyme Analysis in a Rat Model of Colorectal Liver Cancer

    Ultrasound in Medicine and Biology, Vol. 46, Núm. 6, pp. 1504-1512